Featured Health Care Stocks Investing Stock Market News Stock Market Today Stocks to Watch

Best Stocks To Buy Today? 4 Health Care Stocks To Know

As the health care sector continues to show promise, these health care stocks are in focus.

These Health Care Stocks Have Been On Fire In The Market This Year

There is no denying that health care will continue to play a vital role in the economy. Be it good times or bad, health care stocks could always present an opportunity for investors to make substantial gains. According to the Centers for Medicare & Medicaid Services, U.S. health care spending grew by 4.6% in 2019, reaching a whopping $3.8 trillion. Health care also accounted for nearly 18% of the U.S. gross domestic product (GDP) in that same year. If anything, health care demand would have spiked even more given the coronavirus pandemic wreaking havoc throughout the country last year.

The health care industry is very wide and consists of many industries. On one hand, we have biotech companies like Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) who have more than doubled in the last 6 months. On the other, we have drug makers like Regeneron (NASDAQ: REGN) who have come up with amazing treatments in dealing with the health crisis that we face today. Investors are watching the health care sector closely right now as they anticipate successful clinical trials or regulatory approvals. With so many health care companies to choose from, here is a list of top health care stocks to watch in the stock market today.

Best Health Care Stocks To Watch Right Now

Benitec Biopharma

Benitec is an Australian-based biotechnology company. In detail, the company focuses on the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases. With its leading gene therapy capabilities and highly credentialed scientific team, Benitec plays an essential role in the scientific community by advancing novel treatment options. Also, BNTC stock has skyrocketed by over 160% during Tuesday’s trading session and currently trades at $8.31 as of 2:58 p.m. ET.

Source: TD Ameritrade TOS

Investors seem to be responding to a filing with the U.S. Securities and Exchange Commission (SEC). Basically, it was shown that Morgan Stanley (NYSE: MS) has acquired a large amount of BNTC stock. With this recent share purchase, Morgan Stanley now owns a 5.2% stake in Benitec. That should give it enough voting power to influence the company’s future decisions.

Furthermore, its lead candidate BB-301 is a late-stage nonclinical investigational agent that is currently developed for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD). Given the excitement surrounding the company, will you consider buying BNTC stock?

[Read More] Best Industrial Stocks To Buy? 4 Names To Watch Before April 2021

Oramed Pharmaceuticals Inc.

Oramed is a health care company that has developed an innovative technology to transform injectable treatments into oral therapies. To begin with, its flagship product, an oral insulin capsule, has the potential to better the lives of millions of diabetics around the world. Also, the company announced today that it has screened its first patients for its Phase 3 study of its lead candidate, ORMD-0801 for the treatment of type 2 diabetes. ORMP stock currently trades at $10.61 as of 2:59 p.m. ET and has enjoyed gains of over 130% year-to-date.

Source: TD Ameritrade TOS

Last week, the company also announced a joint venture with Oravax Medical Inc. to develop a novel oral coronavirus vaccine. In a preclinical study, the oral vaccine was shown to successfully produce antibodies after just a single dose. The company reported that its candidate offers protection against the coronavirus variants that are currently plaguing the world due to triple antigen targeting.

The oral vaccine will also be much easier for wide-scale distribution and administration as compared to the current method of injection. The company will begin its clinical trial by the second quarter of the year. With that in mind, will you be watching ORMP stock?

Read More

Soliton Inc.

Soliton is a medical device company with a novel and proprietary platform technology. In brief, the company’s first commercial product uses rapid pulses of designed acoustic shockwaves to dramatically accelerate the removal of unwanted tattoos and temporarily improve the appearance of cellulite. Furthermore, the company does this through its Rapid Acoustic Pulse (RAP) device and is engaged in bringing it to the market. Soliton stock currently trades at $17.96 as of 2:59 p.m. ET and has been up by over 12% on today’s opening bell.

Source: TD Ameritrade TOS

Earlier this month, it reported its fourth-quarter and full-year financials and provided an update on its medical device. The company’s RAP has a market target of over 38 million women in the U.S. The company also estimates that 44 million Americans want some form of tattoo removal. Soliton’s medical devices could also cater to a global market of $4 billion by 2023.

Impressively, the company reports that it is able to completely remove treated ink after only 3 treatment sessions. Given the potential use for its product, will you add SOLY stock to your watchlist?

[Read More] Nio (NIO) VS Xpeng (XPEV): Which Of These Electric Vehicle Stocks Is A Better Buy?

Neogen Corporation

Neogen is a health care company that provides a comprehensive range of solutions and services for food processing, animal protein, and agriculture industries. In essence, it is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. Neogen stock currently trades at $86.04 as of 3:00 p.m. ET. The company has just reported its third-quarter results today.

Source: TD Ameritrade TOS

In it, the company’s revenues were up by 17% at $116.7 million compared to a year earlier. On top of that, its third-quarter net income was $13.37 million, a 10% increase year-over-year. Revenues for the company’s food safety segment increased by 16% during the third quarter. This growth was aided in part by international acquisitions within the past year, including Megazyme, a food quality diagnostics company that is based in Ireland.

Also, the company’s animal safety segment enjoyed a growth of 18% in overall revenue. The segment’s performance was led by a 79% increase in sales of rodenticides throughout its product line. Given the impressive financials surrounding Neogen, will you consider buying NEOG stock?

By Adam Lawrence

Adam Lawrence is a serial entrepreneur and financial writer for He calls Miami, Florida his home but has a love for travel. He started his first digital marketing and website design business, in 2006 at the age of 23. He has worked with and consulted for hundreds of publicly traded companies. His vast knowledge of the public markets has allowed him to gain real-world experience in corporate communications. No matter what is going on in the stock market today, Adam is at the front of the line to track new trends and present them to readers.

As an active contributor to other financial sites like GuruFocus and Benzinga, Adam has gained prominence for reporting on several topics. These include biotech stocks, technology stocks, gold stocks, as well as marijuana stocks. These active stock market sectors have presented investors with some of the biggest opportunities in the stock market today. Adam's goal is to present readers with easily digestible content that is both informative and actionable.

Adam's years of experience in digital marketing have helped give him an edge above other financial writers. His ability to pick up on stock market trends before they hit Main Street is one of the things that has afforded him the opportunity to interact with and engage public companies. Reporting on current events is one thing but being able to dissect them and translate them for readers is of the utmost importance. In doing so, Adam has set a personal standard to deliver timely information that dives deeper than simple headlines and goes into the fine details of what's driving stock market trends. He also stays on top of the most current social media trends among top influencers.

With the emerging landscape surrounding new media, Adam takes an active approach to learn what drives interest in different social media and finds ways to tap into whatever is trending at that time then apply it to his approach to the stock market. In his free time, he enjoys being with his family and working on his house. He's also an avid car enthusiast.

Notify of
Inline Feedbacks
View all comments